Patent details

EP4237411 Title: AVACOPAN AND RELATED COMPOUNDS OF FORMULA (I) FOR USE IN THE TREATMENT OF HIDRADENITIS SUPPURATIVA IN PATIENTS HAVING A HURLEY SCORE OF STAGE III

Basic Information

Publication number:
EP4237411
PCT Application Number:
US2021056869
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP218874501
PCT Publication Number:
WO2022093971
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
AVACOPAN AND RELATED COMPOUNDS OF FORMULA (I) FOR USE IN THE TREATMENT OF HIDRADENITIS SUPPURATIVA IN PATIENTS HAVING A HURLEY SCORE OF STAGE III
French Title of Invention:
AVACOPAN ET COMPOSÉS APPARENTÉS DE FORMULE (I) POUR UTILISATION DANS LE TRAITEMENT DE L'HIDRADÉNITE SUPPURÉE CHEZ LES PATIENTS AYANT UN SCORE DE HURLEY DE STADE III
German Title of Invention:
AVACOPAN UND VERWANDTE VERBINDUNGEN DER FORMEL (I) ZUR VERWENDUNG BEI DER BEHANDLUNG VON HIDRADENITIS SUPPURATIVA BEI PATIENTEN MIT EINEM HURLEY-SCORE DER STUFE III
SPC Number:

Dates

Filing date:
27/10/2021
Grant date:
06/05/2026
EP Publication Date:
06/09/2023
PCT Publication Date:
05/05/2022
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/05/2026
EP B1 Publication Date:
06/05/2026
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
27/10/2041
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/04/2026
 
 

Name:
ChemoCentryx, Inc.
Address:
One Amgen Center Drive, Thousand Oaks, CA 91320, United States (US)

Inventor

1

Name:
SCHALL, Thomas J.
Address:
United States (US)

2

Name:
SINGH, Rajinder
Address:
United States (US)

3

Name:
STAEHR, Peter
Address:
United States (US)

4

Name:
LI, Shijie
Address:
United States (US)

Priority

1

Priority Number:
202063106858 P
Priority Date:
28/10/2020
Priority Country:
United States (US)

2

Priority Number:
202063106557 P
Priority Date:
28/10/2020
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/451; C07D 215/54; C07D 405/12; A61P 17/00; A61P 29/00; A61P 37/00;

Publication

European Patent Bulletin

Issue number:
202619
Publication date:
06/05/2026
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
02/11/2026
Annual Fee Number:
6
Annual Fee Amount:
66 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages